Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Merck, Sharp & Dohme — Predicate Candidate Screening
4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K880574 | MODIFIED IMIPENEM SUSCEPTIBILITY POWDER | Merck, Sharp & Dohme | 1988-05-04 | 84 | 0 |
| K864442 | NORFLOXACIN SUSCEPTIBILITY POWDER | Merck, Sharp & Dohme | 1986-12-11 | 29 | 0 |
| K855071 | IMIPENEM SUSCEPTIBILITY POWDER | Merck, Sharp & Dohme | 1986-03-06 | 77 | 0 |
| K760605 | LIGHTCAST II CARBIDE BLADE | Merck, Sharp & Dohme | 1976-10-05 | 27 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda